Your browser doesn't support javascript.
loading
Building resilience needs to be central to treating drug-resistant tuberculosis.
Cox, Helen; Loveday, Marian.
Affiliation
  • Cox H; Division of Medical Microbiology, Department of Pathology, University of Cape Town 7925, South Africa; Institute of Infectious Disease and Molecular Medicine and Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town 7925, South Africa. Electronic address: helen.cox@uct.ac.za.
  • Loveday M; South African Media HIV Prevention Research Unit, South African Medical Research Council, KwaZulu-Natal, South Africa; CAPRISA-MRC HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Lancet Glob Health ; 9(4): e381-e382, 2021 04.
Article in En | MEDLINE | ID: mdl-33740401
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Tuberculosis, Multidrug-Resistant Type of study: Qualitative_research Limits: Humans Country/Region as subject: Africa Language: En Journal: Lancet Glob Health Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Tuberculosis, Multidrug-Resistant Type of study: Qualitative_research Limits: Humans Country/Region as subject: Africa Language: En Journal: Lancet Glob Health Year: 2021 Document type: Article